The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Needles and the damage done: Reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital
Abstract
Objectives To establish the clinical reasons for inpatient admissions among injecting drug users. To determine the frequency of behavioural issues during their care and to estimate the financial implications of injecting drug use to the health service. Methods Retrospective cohort study at University College London Hospital. Clinical, laboratory and financial data were extracted from case notes and electronic records. The cost of each admission was compared to the income received for the period of care. Results 124 injecting drug users required 191 admissions between 2005 and 2009. Skin and soft tissue infections (58%) and pneumonia (18%) were the commonest reasons for admission. Bacteraemia at admission was often not accompanied by an inflammatory response. Exposure to HIV (4%), hepatitis B (49%) and C (84%) was common. Drug misuse (16%) during admission was frequent. The cost to the NHS of treating soft tissue infections in drug users was approximately £77 million per annum. After a median follow-up of 40 months, 10 patients (8%) had died. All deaths were attributable to drug use. Conclusions Bacterial and viral infections are largely responsible for the significant mortality and morbidity of injecting drug users presenting to secondary care. The financial burden to the NHS is substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among people who inject drugs (PWID), skin, soft tissue, and vascular infections (SSTVI) at drug injection sites are the leading cause of emergency department (ED) visits and hospitalizations, globally [5–12].”
Citations
Cites
Hope, V., Kimber, J., Vickerman, P., Hickman, M., & Ncube, F. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-120 · Cited by 112
Predictors of Hospitalization for Injection Drug Users Seeking Care for Soft Tissue Infections
Takahashi, T. A., Baernstein, A., Binswanger, I., Bradley, K., & Merrill, J. O. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0079-y · Cited by 55
Research works printed but not linked: 15
- Hay, 2009, Capture—recapture and anchored prevalence estimation of injecting drug users in England: national and regional estimates, Statistical Methods in Medical Research, 18, 323, 10.1177/0962280208094687 · DOI
- Health Protection Agency, 2011, Unlinked anonymous HIV and viral hepatitis monitoring among IDUs: 2010 update [Internet]
- Islam, 2012, The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature, International Journal of Drug Policy, 23, 94, 10.1016/j.drugpo.2011.08.005 · DOI
- Beaufoy, 1993, Infections in intravenous drug users: a two-year review, The Canadian Journal of Infection Control, 8, 7
- Mertz, 2008, Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis, BMC Infectious Diseases, 8, 42, 10.1186/1471-2334-8-42 · DOI
- Palepu, 2001, Hospital utilization and costs in a cohort of injection drug users, Canadian Medical Association Journal, 165, 415
- Atkinson, 2009, The emergence of methicillin-resistant Staphylococcus aureus among injecting drug users, Journal of Infection, 58, 339, 10.1016/j.jinf.2009.03.004 · DOI
- Huang, 2008, Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection, Diagnostic Microbiology and Infectious Disease, 60, 347, 10.1016/j.diagmicrobio.2007.11.001 · DOI · Paper page
- Lamagni, 2008, Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003–2004, Clinical Microbiology and Infection, 14, 1002, 10.1111/j.1469-0691.2008.02076.x · DOI
- Hope, 2012, A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation, American Journal of Public Health, 102, 122, 10.2105/AJPH.2011.300314 · DOI
- Schroeter, 2009, Outbreak of wound botulism in injecting drug users, Epidemiology & Infection, 137, 1602, 10.1017/S0950268809002544 · DOI
- Bargagli, 2006, Drug-related mortality and its impact on adult mortality in eight European countries, European Journal of Public Health, 16, 198, 10.1093/eurpub/cki168 · DOI
- Bone, 1992, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, Chest, 101, 1644, 10.1378/chest.101.6.1644 · DOI
- Miller, 2003, Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users, European Journal of Clinical Microbiology & Infectious Diseases, 22, 463, 10.1007/s10096-003-0969-4 · DOI
- Turner, 2011, The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence, Addiction, 106, 1978, 10.1111/j.1360-0443.2011.03515.x · DOI
Cited by
Sorted by citations
Yan, M. Y., Gustad, L. T., & Nytrø, Ø. (2022) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab236 · Cited by 119
Wright, T., Hope, V., Ciccarone, D., Lewer, D., Scott, J., & Harris, M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0235350 · Cited by 59
Hope, V. D., Parry, J. V., Ncube, F., & Hickman, M. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.11.003 · Cited by 41
Lim, J., Russell, W. A., El-Sheikh, M., Buckeridge, D. L., & Panagiotoglou, D. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01037-3 · Cited by 3
Metadata
- Authors
- Marks, M., Pollock, E., Armstrong, M., Morris-Jones, S., Kidd, M., Gothard, P., Noursadeghi, M., & Doherty, J. F.
- Venue
- Journal of Infection
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 66
- Issue
- 1
- Pages
- 95-102
- ISSN
- 0163-4453
- Cited by
- 43
- References
- 2
- Language
- en
- Funders
- National Institute for Health Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Needles and the damage done: Reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital. https://app.cochat.ai/papers/10.1016/j.jinf.2012.10.004
- The paper
- Marks, M., Pollock, E., Armstrong, M., Morris-Jones, S., Kidd, M., Gothard, P., Noursadeghi, M., & Doherty, J. F. (2013). Needles and the damage done: Reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital. Journal of Infection. https://doi.org/10.1016/j.jinf.2012.10.004
